Dragon Study (the Safety and Efficacy for Treatment of Patients With Complicated Intra Abdominal Infections)

NCT00769171 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

364

Enrollment

INDUSTRY

Sponsor class

Conditions

Infection, Intra-abdominal

Interventions

DRUG: Avelox (Moxifloxacin, BAY12-8039)
DRUG: Ceftriaxone + Metronidazole

Sponsor

Bayer